Oberlander Coauthors NEJM Commentary on Prescription Drug Spending

Jonathan Oberlander, PhD, chair of the Department of Social Medicine, coauthored a perspective in the New England Journal of Medicine on efforts in Congress to pass legislation that would regulate prescription drug prices.